BioResearch



PARP-Inhibitors Reduce Damage in Some Neurological Disorders
A recent study found that blocking the activity of the poly(ADP-ribose)polymerase (PARP) family of enzymes reduced the amount of harmful TDP-43 (transactive response DNA binding protein) structures in brain cells under stress and slowed or prevented development of cytoplasmic inclusions found in neurological disorders such as amyotrophic lateral sclerosis (ALS), and some forms of frontotemporal degeneration (FTD). More...20 Aug 2018




In Other News
Conditions in the Tumor Microenvironment Change Role of p53
Norovirus Binding Requires Attachment to Fucose Residues
Stem Cell-Based Cultures Used for Brain Disease Research
Bacteriophages Delivered by Dry Powder Cure Lung Diseases in Model
Mitochondrial DNA Depletion Linked to Depletion Syndromes
Cancer Growth Promoted by an Oncogenic MicroRNA
Adsorption Procedure Enhances Efficiency of Drug Transport
Synthetic Fatty Acid Derivatives Display Anti-Cancer Potential
Protein Combination Reduces Muscle Damage in ALS Model
Mechanism Regulates Organelle Distribution during Cell Division
Model Defines Role of Reactive Oxygen Species in Neural System Development
Teratomas Offer Source for Rebuilding Damaged Tissues
Novel Bacterial Inhibitor Blocks Lysozyme Activity in Model
MicroRNA Biomarker Identified for Bladder Cancers
Genetic Code Expansion Used to Establish Biological Control Mechanism
MicroRNAs Changes Precede Symptoms in Tauopathies
Identifying Potential Drugs that Modify RNA Expression
DNA Replication Determines Cell Cycle Duration
Cryo-EM Reveals How Malaria Parasites Invade Blood Cells
CRISPR/Cas9 Corrects Symptoms of Fragile X Syndrome in Model
RNA-Based Gene Therapy Developed for Cystic Fibrosis
Enzyme Elimination Blocks Exosome Release and Slows Cancer
Excess Inflammasome Activity Leads to Formation of Atherosclerosis
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.





.jpg)

